Actively Recruiting
Enhancing Language Function in Primary Progressive Aphasia
Led by University of Arizona · Updated on 2024-11-29
20
Participants Needed
1
Research Sites
302 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study's goal is to use non-invasive brain stimulation (NBS) techniques to treat language impairment associated with Primary Progressive Aphasia (PPA). The purpose of this study is to combine behavioral language intervention with individualized noninvasive brain stimulation techniques, called transcranial direct current stimulation (tDCS) to help the brain reorganize around damage and improve language functions.
CONDITIONS
Official Title
Enhancing Language Function in Primary Progressive Aphasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Primary Progressive Aphasia by a neurologist or speech-language pathologist
- Having a speech-language deficit caused by Primary Progressive Aphasia
- Native speaker of English or equivalent proficiency
- Adequate vision (normal or corrected to normal)
- Adequate hearing
You will not qualify if you...
- Diagnosed with mood, anxiety, psychotic, or substance abuse disorders according to DSM-IV criteria
- Having highly magnetizable metallic implants or certain dental work
- Diagnosed with neurological disorders other than PPA, such as epilepsy, Multiple Sclerosis, or Parkinson's Disease
- Having contraindications for MRI
- Having pacemakers, metallic cardiac pumps, valves, or magnetic surgical clips
- Experiencing clinically significant claustrophobia
- Having severe systemic diseases like renal failure or poor general health
- Being pregnant
- Having epileptic activity in the past 12 months or a family history of epilepsy or seizure disorders
- History of brain surgery
- Having metallic skull plates or implants
- Having skin lesions or skull damage
- Excessive use of alcohol or drugs
- Premorbid psychiatric disease affecting communication
- Severe non-linguistic cognitive disturbances that interfere with language therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Arizona
Tucson, Arizona, United States, 85721-0071
Actively Recruiting
Research Team
A
Aneta Kielar, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here